Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Placing Participation

3 Dec 2009 14:00

RNS Number : 5491D
Pantheon Leisure PLC
03 December 2009
 



Pantheon Leisure plc / Epic: PLEI / Market: AIM / Sector: Leisure

3 December 2009

Pantheon Leisure plc ('Pantheon' or 'the Company')

Placing Participation

The Board of Pantheon Leisure plc, the AIM quoted company formed to acquire businesses in the leisure sector, is pleased to announce that as part of a wider fundraising and capital reorganisation undertaken by ADDleisure plc ("ADDleisure") announced today, conditional on, inter alia, ADDleisure shareholder approval at a forthcoming ADDleisure general meeting to be held on 21 December 2009, the Company's short term loan to ADDleisure of £100,000 is to be repaid in full. In recognition of the provision of this loan, ADDleisure has agreed to grant to Pantheon an option over 100,000 new ordinary shares of 1 pence each in ADDleisure exerciseable at 10p per share ("ADDleisure Options"). The ADDleisure Options will be exerciseable at any time from the date of grant for a period of three years thereafter. 

In addition, the Directors believe that ADDleisure represents an attractive investment opportunity with its focus on Fitbug. Fitbug offers online personal health and well-being services by combining interactive tracking devices and web technology to measure activity and health indicators, provide feedback and motivate the user towards a healthier lifestyle. It is mainly focussed on the corporate wellness and health insurance sectors, with increasing effort being placed on the public health arena. Its blue-chip client base includes Nectar, PruHealth, BUPA, various Primary Care Trusts and Holmes Place Group. Fitbug also sells its products directly to individual consumers through its website, fitbug.com, as well as other retailers including Amazon and WH Smith. The Company is therefore subscribing for 1,000,000 new ADDleisure ordinary shares of 1p each at a placing price of 10p per share as part of ADDleisure's £1.2 million placing announced today.

The placing participation and the receipt of ADDleisure Options by Pantheon is a related party transaction within the meanings of the AIM Rules. Barbara Moss and Irvin Fishman, being the independent directors for the purpose of the placing participation, having consulted with Seymour Pierce Limited, the Company's Nominated Adviser, considers the terms of the placing fair and reasonable.

 

Commenting on the participation in the ADDleisure placing, Bill Weston, Chairman of Pantheon, said "We are delighted to be able to support ADDleisure which, through Fitbug, is focused on people's wellbeing through activity. This is something close to our heart with our Sport for School initiative as well as our small sided football leagues."

 

* * ENDS * *

For further information please visit www.pantheonleisure.com or contact:

Geoffrey Simmonds

Pantheon Leisure plc

Tel: 020 7935 0823

Mark Percy

Seymour Pierce Limited

Tel: 020 7107 8000

Isabel Crossley

St Brides Media & Finance Limited

Tel: 020 7236 1177

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOOORKNRURAA
Date   Source Headline
5th Oct 20224:35 pmRNS£10m Placing/Subscription ABB & Rex Retail Offer
21st Sep 20224:40 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20222:05 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:21 amRNSRevised Market Forecasts
20th Sep 20227:03 amRNSBidstack Expands US Operation with CRO Hire
20th Sep 20227:00 amRNSStrategy for Accelerated Growth in the US
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20223:50 pmRNSNew IAB Intrinsic In-Game Measurement Standards
17th Aug 20227:00 amRNSSports Interactive, exclusive multi-year renewal
8th Aug 20227:00 amRNSInterim Results - six months ended 30 June 2022
11th Jul 20227:00 amRNSAsia-Pacific enterprise software deal
7th Jul 20224:40 pmRNSSecond Price Monitoring Extn
7th Jul 20224:35 pmRNSPrice Monitoring Extension
7th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSAppointment of Chairman Designate
24th May 202211:03 amRNS2022 AGM Results
23rd May 20227:00 amRNSHolding in Company
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSBidstack adds four games from Highbrow Interactive
28th Apr 20225:15 pmRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSBidstack Expands Portfolio With New Partnership
27th Apr 20227:00 amRNSFinal Results
8th Apr 202211:05 amRNSSecond Price Monitoring Extn
8th Apr 202211:00 amRNSPrice Monitoring Extension
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 202211:05 amRNSSecond Price Monitoring Extn
21st Mar 202211:00 amRNSPrice Monitoring Extension
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 20229:00 amRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSBidstack partners with GroupM’s Xaxis
3rd Mar 20228:00 amRNSBidstack partners farm simulation game Goodville
25th Feb 20224:40 pmRNSSecond Price Monitoring Extn
25th Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20227:00 amRNSBidstack adds 3 new titles from Game Tap Studios
8th Feb 20227:00 amRNSAppointment of CTO/CPO
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSChange of Registered Office
10th Jan 20229:00 amRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
6th Jan 202211:06 amRNSSecond Price Monitoring Extn
6th Jan 202211:00 amRNSPrice Monitoring Extension
22nd Dec 20217:00 amRNSAdoption and Grant of LTIP Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.